EyePoint Pharmaceuticals Files 8-K/A Amendment

Ticker: EYPT · Form: 8-K/A · Filed: Jul 29, 2025 · CIK: 1314102

Eyepoint Pharmaceuticals, Inc. 8-K/A Filing Summary
FieldDetail
CompanyEyepoint Pharmaceuticals, Inc. (EYPT)
Form Type8-K/A
Filed DateJul 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: amendment, filing-correction

TL;DR

EyePoint Pharma filed an amendment to an 8-K, likely correcting or adding info. Formerly pSivida.

AI Summary

EyePoint Pharmaceuticals, Inc. filed an 8-K/A on July 29, 2025, to amend a previous filing. This amendment pertains to Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The company was formerly known as pSivida Corp. and pSivida LTD.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information by EyePoint Pharmaceuticals.

Risk Assessment

Risk Level: low — This is a routine amendment filing, not indicating new material events or financial distress.

Key Players & Entities

  • EyePoint Pharmaceuticals, Inc. (company) — Registrant
  • pSivida Corp. (company) — Former company name
  • pSivida LTD (company) — Former company name
  • July 29, 2025 (date) — Date of report

FAQ

What specific information is being amended in this 8-K/A filing?

The filing indicates amendments related to Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), but the specific details of the amendment are not provided in this excerpt.

When was the original 8-K filing made that this 8-K/A amends?

The filing date of this 8-K/A is July 29, 2025, and it amends a previous report. The date of the original filing is not specified in this excerpt.

What were the previous names of EyePoint Pharmaceuticals, Inc.?

EyePoint Pharmaceuticals, Inc. was formerly known as pSivida Corp. and also as pSivida LTD.

What is the principal executive office address for EyePoint Pharmaceuticals, Inc.?

The principal executive offices are located at 480 Pleasant Street, Suite C400, Watertown, Massachusetts 02472.

What is the SIC code for EyePoint Pharmaceuticals, Inc.?

The Standard Industrial Classification (SIC) code for EyePoint Pharmaceuticals, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.

Filing Details

This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 29, 2025 regarding EyePoint Pharmaceuticals, Inc. (EYPT).

View full filing on EDGAR

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.